Home

Lori Firmani

CIK 1808248 · Chief Financial Officer · last filed 2026-01-06

Lori Firmani is a Chief Financial Officer who has filed 6 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for DMRA, was dated Jun 22, 2026. Across all open-market trades the lifetime net is −$5.7K, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

6

Lifetime Open-Market Net

-$5.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Damora Therapeutics, Inc. (GLTO) Delisted Chief Financial Officer 1,066 $28.69 $30.6K -$4.9K 4 2026-01-06
F-star Therapeutics, Inc. (SBPH) Delisted VP of Finance and Treasurer 18,042 — — -$833 1 2020-11-23

Recent Filings

6 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-22 DMRA Notice (144) −7,615 -$193.1K EDGAR
2026-01-06 Damora Therapeutics, Inc. (GLTO) Delisted Mixed +239 -$2.9K EDGAR
2025-07-08 Damora Therapeutics, Inc. (GLTO) Delisted Mixed +227 -$498 EDGAR
2025-01-07 Damora Therapeutics, Inc. (GLTO) Delisted Mixed +465 -$1.5K EDGAR
2024-10-11 Damora Therapeutics, Inc. (GLTO) Delisted Grant (A) — $0 EDGAR
2020-11-23 F-star Therapeutics, Inc. (SBPH) Delisted Mixed +16,075 -$833 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.